In 1978, nearly two decades after the discovery of messenger RNA (mRNA), the concept of a vaccine made from mRNA was materialized. Like its name suggests, mRNAs are messengers that…
Results from a Phase I trial showed promising safety and efficacy of a potential first vaccine against the mosquito-borne Zika virus, developed by French biotech Valneva and US biopharma Emergent…
Researchers may have found a way to stop the female mosquitoes from biting you, which could help to prevent the spread of diseases like malaria. Scientists at the University of…
Tropical diseases are often neglected until an outbreak causes worldwide panic. Here’s how European biotech is preparing for the next one. “What we really need is a very fast and…
In our fireside chat with Hadyn Parry, Clara had the chance to hear all about Oxitec's exciting technology that could save us from Dengue and Zika. Oxitec's GM mosquitoes have the…
Despite remaining firmly in academia, Greg Winter is a biotech legend. What's ahead for the serial entrepreneur, and where does he see biotech going? Sir Greg Winter is one of…
Researchers from the Institut Pasteur and the Inserm have identified a protein target that, when overexpressed, can block Zika infections. The recent Zika epidemics in the Pacific and South America…
In its second year, Oxitec has reduced the mosquito population in a Brazilian neighborhood by 81%, demonstrating the long-term potential of GM insects. Oxitec is a spin-out from the University…
CEVEC Pharmaceuticals recently partnered up with NewLink Genetics to use its CAP technology for the development of new vaccines against the Zika virus. We had the opportunity to ask CEVECs CSO a…
Oxitec is preparing to start trials testing its solution to reduce the population of disease-transmitting insects in India with its own genetically modified mosquitoes. Oxitec, a spin-out from Oxford University,…
Since Brazil became the first country in the world to deploy GM mosquitos, Oxitec has opened a factory there to produce its Friendly Aedes aegypti. Oxitec has opened a large-scale…
From Switzerland, we depart once again, this time for Vienna. This week, we are visiting Themis Bioscience, our Biotech of the Week (and also stopping for schnitzel). City: Vienna, Austria Founded:…
These potentially fatal diseases have reached pandemic proportions and are starting to threaten the Western world. Excivion (UK) and Xenetic (US) have announced a partnership to develop a combined vaccine for Dengue…
A court finally allowed the release of Oxitec's 'friendly' mosquitoes in the Grand Cayman (1 of the 3 islands). If the technique repeats its recent successes, the local population of…
The grapefruit aroma nootkatone is now in field trials to assess its effectiveness against mosquitoes that spread the Zika virus. Good news for Evolva, which figured out a SynBio process…
Themis is a Vienna-based vaccine developer. Together with the Institut Pasteur, it is now planning to use a measles vaccine construct to develop and start Zika vaccine trials within the next 12 months. Themis has successfully…
Oxitec (UK) is on track to be allowed to trial their self-limiting, genetically engineered mosquitoes in the US - and stop the spread of Dengue and Zika. As a spin-off…
The Zika virus epidemic could infect up to 4 Million people. As a cousin to Dengue Fever, what are the risks? Who in the Biotech and pharma world are working…